14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ADXS stock ended at $0.550. This is 0.90% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 3.68% from a day low at $0.531 to a day high of $0.550.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Advaxis prices

Date Open High Low Close Volume
May 14, 2020 $0.710 $0.750 $0.689 $0.706 813 319
May 13, 2020 $0.790 $0.80 $0.653 $0.696 1 883 158
May 12, 2020 $0.83 $0.83 $0.761 $0.790 1 968 996
May 11, 2020 $0.750 $0.81 $0.724 $0.773 2 804 014
May 08, 2020 $0.720 $0.750 $0.690 $0.729 1 195 145
May 07, 2020 $0.720 $0.750 $0.710 $0.720 1 299 531
May 06, 2020 $0.659 $0.730 $0.652 $0.706 1 979 415
May 05, 2020 $0.670 $0.689 $0.640 $0.652 502 413
May 04, 2020 $0.620 $0.675 $0.620 $0.660 563 839
May 01, 2020 $0.670 $0.670 $0.620 $0.650 782 115
Apr 30, 2020 $0.700 $0.710 $0.650 $0.671 833 031
Apr 29, 2020 $0.740 $0.749 $0.680 $0.700 1 651 521
Apr 28, 2020 $0.680 $0.727 $0.650 $0.720 2 230 384
Apr 27, 2020 $0.600 $0.658 $0.590 $0.655 1 548 440
Apr 24, 2020 $0.585 $0.592 $0.566 $0.587 755 102
Apr 23, 2020 $0.592 $0.596 $0.570 $0.585 744 633
Apr 22, 2020 $0.602 $0.628 $0.575 $0.589 1 154 239
Apr 21, 2020 $0.650 $0.650 $0.580 $0.610 1 008 083
Apr 20, 2020 $0.640 $0.650 $0.600 $0.616 1 096 851
Apr 17, 2020 $0.630 $0.649 $0.603 $0.635 1 420 628
Apr 16, 2020 $0.660 $0.660 $0.620 $0.630 837 474
Apr 15, 2020 $0.656 $0.660 $0.610 $0.658 1 076 800
Apr 14, 2020 $0.650 $0.680 $0.640 $0.663 1 181 011
Apr 13, 2020 $0.680 $0.686 $0.600 $0.633 1 166 183
Apr 09, 2020 $0.670 $0.700 $0.670 $0.687 1 586 814
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT